Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 2Biophore India Pharmaceuticals Pvt Ltd
02 1ANDA Repository
03 1Amphastar Pharmaceuticals
04 1Annora Pharma
05 13Bayer AG
06 7Bracco
07 2Farmak JSC
08 8GE Healthcare Inc
09 2Grupo Juste
10 1Iberoinvesa Pharma Sl
11 5Mallinckrodt Pharmaceuticals
12 1Xian Libang Pharmaceutical Co.,Ltd
01 4AMP
02 1FOR SOLUTION;ORAL, RECTAL
03 18INJECTABLE;INJECTION
04 1Injectable Solution
05 3Injection
06 3LIQ
07 3Oral And Rectal Solution
08 1SOLUTION
09 6SOLUTION;ORAL, RECTAL
10 1SOLUTION;URETERAL
11 1Solution For Injection And Infusion
12 2Solution for Injection
01 5Authorized
02 22DISCN
03 1Ethical
04 7Originator
05 4RX
06 5Blank
01 1ANGIOVIST 292
02 1ANGIOVIST 370
03 1Amidotrizoato De Sodio Y Amidotrizoato De Meglumina Iberoinvesa Pharma
04 2DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
05 1DIATRIZOATE-60
06 2GASTROGRAFIN
07 1GASTROVIST
08 2Gastrografin
09 1Gastrolux
10 4HYPAQUE
11 1HYPAQUE SODIUM 20%
12 1HYPAQUE-76
13 1HYPAQUE-M,75%
14 1HYPAQUE-M,90%
15 1MD-50
16 1MD-60
17 1MD-76
18 1MD-76R
19 1MD-GASTROVIEW
20 1Plenigraf
21 1RENOCAL-76
22 1RENOGRAFIN-60
23 1RENOGRAFIN-76
24 1RENOVIST
25 1RENOVIST II
26 2Triombrast
27 1UROVIST SODIUM 300
28 1Urografin
29 2Urografin 30%
30 2Urografin 60%
31 2Urografin 76%
32 3Blank
01 1Canada
02 1China
03 2India
04 7South Africa
05 5Spain
06 26USA
07 2Ukraine
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 76%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Diatrizoate Sodium; Diatrizoate Meglumine
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 52%;8%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST II
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 28.5%;29.1%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 34.3%;35%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : GASTROGRAFIN
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 11245
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%
Packaging :
Approval Date : 1982-01-01
Application Number : 9561
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE SODIUM 20%
Dosage Form : SOLUTION;URETERAL
Dosage Strength : 20%
Packaging :
Approval Date : 1982-01-01
Application Number : 9561
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 25%
Packaging :
Approval Date : 1982-01-01
Application Number : 9561
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,90%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%;30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,75%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%;25%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : FOR SOLUTION;ORAL, RECTAL
Dosage Strength : 100%
Packaging :
Approval Date : 1982-01-01
Application Number : 11386
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 40%
Packaging :
Approval Date : 1982-01-01
Application Number : 11386
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 86505
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-76R
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1989-09-29
Application Number : 19292
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 87073
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 52%;8%
Packaging :
Approval Date : 1982-01-01
Application Number : 87074
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MD-50
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%
Packaging :
Approval Date : 1982-01-01
Application Number : 87075
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : MD-GASTROVIEW
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 87388
Regulatory Info : RX
Registration Country : USA
